U.S. SEC Issues Order Declaring Allarity Therapeutics Inc.'s Form S-4 Registration Statement Effective Ahead of Planned Transition to U.S. Nasdaq
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Source: apnews.com